Latest News



September 25, 2019 1

In its ongoing commitment to raising awareness of mental health conditions and treatments and to help the millions of suffering adults, Allergan launched a new campaign for VRAYLAR earlier this month. To represent the ups and downs of mood swings associated with bipolar I disorder, the campaign showcases a woman viewing various episodes of her life as she rides up and down in a shaky elevator.

In “The Ups and Downs Campaign,” upon entering the elevator and pressing the button to her floor, all of the button lights begin to flicker rapidly. The elevator plummets down, with the doors then opening to show her crying on the edge of her bed, before surging back up high, where the doors open on a scene of her arguing with a man. The elevator screen then shows the arrows pointing in both directions, as the doors open to reveal her clothes shopping in a panicked state. After taking VRAYLAR, the elevator ride steadies before stopping in her current life moment where she cleans up the mess in her bedroom, and then takes a smooth elevator ride to meet her date in the lobby.

The creative was shaped by “insights and anecdotes shared by” bipolar I disorder patients, according to the public relations team. “Using physical metaphors taken from how patients describe the condition,” this illustration helps describe the mood episodes as well as the transitions between, covering the full spectrum of bipolar I symptoms: depression, mixed episodes, and mania. The next stage of this campaign will introduce another visual, “inspired by real analogies real patients made about how the ups and downs of bipolar can feel. The intention is to help more people who may be living with the condition recognize the symptoms, and talk to their doctors to see appropriate treatment.”

The campaign includes in-network and cable spots, running in all time periods of the day but with a particular attention to specific shows. Print and newly designed website companion elements launched mid-month. BBDO created the ad; BCW supports the PR and strategic communications efforts for the brand.

admin


September 25, 2019 0

Three new member companies have joined the Point of Care Communication Council (PoC3), as announced this month: CoverWrap Communications, Rx EDGE Media Network, and Targeted Media Health (a division of Meredith Corporation). In addition to “[helping] influence and amplify the future of POC marketing. In the near term, they plan to immerse into the PoC3 Verification & Validation Guidance effort and the establishment of measurement best practices.”

David M. Kenyon, CEO at CoverWrap Communications, Nate Lucht, President & CEO of Rx EDGE and Leverage Point Media, John Kenyon, VP and Managing Director with Targeted Media Health, were all in agreement as they shared their enthusiasm in joining PoC3 and helping to advocating for and strengthening the point of care space, as per the news release.

Karen Newmark, Executive Director with PoC3, shared how this continued expansion helps the association lead the progress: “PoC3 has grown tremendously over the past year, and we anticipate the growth increasing in 2020. We expect to see different types of companies, all with common interest in the PoC3 mission, wanting to build on the unprecedented momentum in the POC channel.”

Click here to read the complete news release and full team member statements: https://www.poc3.org/post/point-of-care-communication-council-welcomes-three-new-members.

admin


September 24, 2019 0

The custom campaign, In These Rooms, launched this month to help transform the point of care space to a more empathetic “moments of care” image. Created by Outcome Health, a 90-second video was released which portrayed life-changing moments that patients and caregivers experience in waiting rooms and exam rooms. According to a news release, In These Rooms depicts “raw, authentic emotion” to create a shift in mindset when it comes to healthcare content in these locations and channels. The long-form video will be complemented by shorter spots – distributed via selected healthcare trade support – as well as a social media campaign.

To provide a well-rounded representation of potential patient and caregiver experiences with their healthcare professionals, the creative includes: “a waiting room, a pediatrician visit for an asthma check-up, an OB-GYN ultrasound room to hear a baby’s first heartbeat, a standard exam room for a long-overdue physical, and a doctor’s office to learn about treatment results.”

Matt McNally, CEO of Outcome Health and DTC Innovator honoree, stated in the news release: “In These Rooms challenges all pharma marketers and their agency partners to think differently about point of care and is the first step in our commitment to the ongoing understanding of the needs in this space. Today, we call on our industry to create content and experiences that wrap patients with empathy, education and support at the ‘moments of care’ when they are most vulnerable and need it most.”

admin


August 28, 2019 0

 

It’s been five years since Gartner called Prescriptive Analytics “the final frontier for Big Data, where companies can finally turn the unprecedented levels of data into powerful action.” Will prescriptive analytics be the final frontier for health marketers?

Pharma Marketers’ Analytics Adoption Curve

Let’s start by understanding where pharma marketing is on the analytics adoption curve.

  • Do you retroactively analyze what happened with your media campaigns? If YES, you’re using Descriptive Analytics.
  • Do you evaluate, in a deliberate and controlled fashion, why it happened? If YES, you’re using Diagnostic Analytics.
  • Do you have enough data and intelligence to predict what is most likely to happen? If YES, you’re using Predictive Analytics.
  • Do you use logic and math to decide how to make it happen? If YES, you’re using Prescriptive Analytics.

While almost all pharma marketers are using Descriptive and Diagnostic Analytics to a certain extent to measure and evaluate their media campaigns, no one to my knowledge is using Predictive and Prescriptive Analytics approaches with measurable success in health. The approach has been used successfully in mass brands for marketing, and in pharma for supply chain management, customer service modeling, and even clinical trial management, but not for marketing and media.

What Prescriptive Analytics Could Look Like

And yet we talk about prescriptive analytics because the promise is extraordinary. Let’s imagine the possibility.

For example, every month nearly 100 million people visit Healthline. With big data models, we would be able to predict the condition profiles of our readers, what content they’re going to read, what ads they’re going to click on, and what brands they will ultimately buy. With that information, we could use AI in real time to individualize and personalize the experience for each reader and determine which ad unit(s) to show them, in which platform (site, social network, newsletter), and in what order, to influence specific behaviors such as visiting a particular website page, and delivering a specific outcome like a new brand start.

Sponsoring brands could manage the reach of their ad campaigns and forecast the increased demand generated by their ad spend far more accurately. The prospect is enticing.

Limitations of Prescriptive Analytics in Health Marketing

Before we fully embrace the allure, let’s recognize some of the limitations of predictive analytics in health marketing.

  • The scale of the data just doesn’t exist. Sure, if we’re talking about a condition like flu, which affects large swaths of the world’s population, we may be able to build models that work. But what about advanced metastatic breast cancer? Or ankylosing spondylitis? The numbers of cases of these conditions are small, so the predictive power is far from confident and the models fall apart.
  • Media campaigns don’t really relate to each other. To get the historical learning at scale, we’d need to combine the learning across all media campaigns, across all brands, even across all conditions. But brands are different. Insights are different. Messages and levers are different. The experience from one campaign doesn’t apply to another, even though the holistic experience can yield powerful insights.
  • The patient journey is truly individual. Perhaps, with really big data sets, we can find demographic or behavioral markers that correlate with condition profiles, advertising sensitivity, or likelihood to get on brand. But the correlation won’t be high, and won’t necessarily portend future behavior. It’s because health is multifactorial and every person is truly unique. Not everyone with advanced metastatic breast cancer is the same. They live under different economic conditions, social determinants, value systems, and risk curves. There may exist a handful of people who mimic similar behaviors, but never segments large enough to truly validate the effort.
  • Last but not least, patient privacy protection limits widespread use of patient data. Industries leveraging prescriptive analytics with machine learning and artificial intelligence have significantly fewer barriers than health and pharma marketers. HIPAA makes data matching and outcomes-based analysis extremely challenging. Add to that the data loss now with GDPR and CCPA, further diminishing the sample sizes available for testing and optimizing, and making universal recommendations impossible.

How Pharma Can Be Data-Driven

Instead of chasing big data models, marketers can be predictive and prescriptive with their media campaigns by using descriptive and diagnostic data combined with human computing: human discernment, sensitivity, and gumption.

Here are our four principles:

  1. Live by the data. Continue to invest in machines to run the decision rules behind your dashboard, alerting you when a campaign is in the “red” or “green” zone. But make sure you have empathetic humans available to receive those alerts and act on them.
  2. Surround yourself with a team of competitive hard-core analysts. They’re hard-wired to go beyond current standards. They’re your human engine, to fine-tune future results and predict future results.
  3. Be smarter about how you use historical data. Ask “What worked?” Also, scenario plan by asking “What could work better?” to understand and perfect campaign effectiveness. Be strategic. Start with the end goal in mind, test and experiment, and deftly piece together the answers to “how” and “why.”
  4. Optimize actively, not passively. When your agency or partner presents their optimization approach, don’t gloss over that section. Approach optimization as a critical strategic lever. Build rapid review cycles, and learn and codify that learning everyday.

Prescriptive analytics gives us an ideal to aspire to, but not something we can realistically participate in today. However, we can take the key principles from that ideal and incorporate them in the way we run our campaigns. We can adhere to scientific rigor, transparency, and connecting humans to the numbers to rethink and refine campaigns. For now, it may not be a golden goose, but it’s not an empty promise either.

 

Jennifer Loga


August 28, 2019 0

The Department of Health and Human Services (HHS) filed a notice of appeal on August 21st in response to the July ruling that blocked price disclosure in TV drug advertising. Handed down by Judge Amit Mehta of the US District Court, he ruled against the measure, stating: “HHS lacks the statutory authority under the Social Security Act to adopt the WAC [wholesale acquisition cost] Disclosure Rule.” At the time of his decision, HHS seemed to hint that they were going to file an appeal, saying they would “work with the Department of Justice on next steps related to the litigation.”

In May of this year, HHS outlined their plan for the WAC Disclosure Rule. Amgen, Merck, and Eli Lilly, joined by the Association of National Advertisers, filed a lawsuit in mid-June to prevent it from going into effect. Judge Mehta sided with the plaintiffs in early July. The price disclosure rule for TV advertising would apply to drugs with a list price of $35 or higher for a 30-day supply.

admin


August 28, 2019 0

Ogilvy Health, a part of Ogilvy, has promoted seven creative team members in the agency's New Jersey and New York offices. Expressing her excitement for the department's growth was Ogilvy Health North America's Chief Creative Officer, Samantha Dolin: “I couldn’t be more thrilled to see this group acknowledged for their respective talents and collective leadership. Their brilliant contributions every day help to elevate the entire Ogilvy Health team and the new roles they are taking on will allow their impact to be felt more broadly across so many of our key accounts. As they continue to drive meaningful results and delight our clients, I am looking forward to building our next creative chapter with this group of tremendously talented individuals.”

The new advancements are:

  • Mike Brune and Deborah Ciauro have been promoted to the positions of Executive Creative Directors.
  • Larry Hannon has been elevated to Senior Vice President, Creative Director.
  • Beth Elkis and George Giunta have advanced to the posts of Group Creative Directors.
  • Anita Caruso has moved to Vice President, Associate Creative Director.
  • Agnes Topor has advanced to Associate Creative Director.
Mike Brune
Deborah Ciauro
Larry Hannon
Beth Elkis
George Giunta
Anita Caruso
Agnes Topor

admin


August 28, 2019 0

HCB Health announced the hiring of ten new team members under its BioPharma division and an additional four to support the agency across all groups. Of the new hires, three will take on roles in senior management: Gabriel Cangiano, Mark Davis, and Travis Waggoner.

New BioPharma team members:

  • Denise Byrne joins as Senior Project Manager in HCB Health's Chicago location. Denise was previously a Senior Project Manager at Havas Life Metro.
  • Leslie Calabrese joins as Assistant Account Executive in Chicago. Leslie was a Social Engagement Associate at Golin prior to this role.
  • Gabriel Cangiano serves as VP, Group Account Supervisor in Chicago. Gabriel joins from GC Healthcare Consulting, having been a Consulting Director, and InTouch Solutions, where he was a Group Account Director, HCP and Market Access.
  • Brooke Claussen is an Associate Creative Director in Chicago. Brooke was with InTouch Solutions previously as an Associate Creative Director.
  • Nick D'Amore serves as Medical Editor in West New York / New Jersey. Nick was with FCB Health as a Senior Medical Editor previously.
  • Ethan Stickle joins as Account Supervisor in Chicago. Most recently, he work for The Sandbox Agency as Account Supervisor.
  • Pooja Desai holds the role of Senior Account Executive in Chicago. Pooja was a Senior Account Executive with EVERSANA previously.
  • Christine Mavridis (Chris Mav) is an Associate Creative Director in the Raleigh-Durham, North Carolina office. Most recently, Chris was a Group Copy Supervisor with McCann Health.
  • Julyna Moore is a Senior Art Director in Chicago, having previously held the Senior Art Director role at AbelsonTaylor.
  • Ruth Nobile joins as an Account Executive in the Austin location. Most recently, Ruth, a postdoctoral marketing fellow, was with Bayer Pharmaceuticals in US Oncology Marketing.

Supporting the entire agency:

  • Cody Morris is now an Associate UX (user experience) Designer, working in the Austin location. He was previously a contract / freelance graphic designer.
  • Mark Davis holds the role of SVP Multichannel Delivery in New Jersey. Prior to that, he was a healthcare digital marketing consultant, and was with Sudler & Hennessey as a SVP, Digital Strategist.
  • Travis Waggoner serves as IT Director in Austin. Travis was previously with TeamLogicIT as a Solutions Engineer / Technical Delivery.
  • Kelsi Brown joins as Director of Employee Engagement in Austin. Previously, Kelsi was a Senior HR Manager at T3.

admin


July 26, 2019 0

The US Department of Health and Human Services (HHS) has awarded nearly $42 million in funding to 49 Health Center Controlled Networks (HCCNs). HCCNs work together to improve access to and quality of care, as well as leverage health information technology to cut costs and improve care coordination. The funding came through the Health Resources and Services Administration (HRSA) as the HCCNs expand their usage of health information technology to empower patients and promote data sharing.

“Health centers play a crucial role in providing their communities with access to high quality, affordable healthcare,” said HHS Secretary Alex Azar in the news announcement. “Investing in more advanced health IT will help put patients at the center and unleash the power of data, helping us get better value from the care delivered by health centers and delivering on President Trump’s vision for healthcare.”

“Improvements in information technology will enhance the patient and provider experience as health centers continue to deliver high quality primary care in underserved communities across the nation,” said HRSA Administrator Dr. George Sigounas. “President Trump is determined to support and improve the ability of health centers to work together and deliver value-based care.”

admin

Doctors-Office-POC.webp

July 26, 2019 0

 

I sat down with Charlie Greenberg, a respected healthcare industry veteran and an expert in point-of-care (POC) marketing, to discuss current trends in healthcare marketing. It’s a topic Charlie knows well, having worked for more than 30 years in the industry with giants like Saatchi & Saatchi, Wyeth, and Merck. Charlie currently serves as a media and marketing consultant, so he spends a great deal of time thinking about the ways brands can improve their reach and maximize their return on investment.

Q: How has healthcare marketing changed during your time in the industry?

A: Market research on patient population profiles and their attitudes toward treatment options has become increasingly more sophisticated. We no longer focus only on demographics and affinity interests, but now incorporate attitudes toward treatment options, healthcare status, and relevant multicultural distinctions within an overall target universe.

Paid media in the marketing mix has embraced this more sophisticated market research by employing greater targeted media tactics. This is not only a function of the evolution of digital media but greater opportunities within the point-of-care arena and the availability to refine how mass media can reach a target audience.

Q: What's the biggest thing healthcare marketers aren't doing that they should, or that they should be doing more of?

A: Good marketers set themselves apart from the pack when they are willing to make bold decisions and address the marketplace by shaping customer thinking. Adopting a mindset of “test and learn” around how marketing dollars are spent needs to be better embraced. Short-term thinking often leads to stagnation and missed opportunities.

Secondly, marketers should also be investing more in communication which has the goal of building health literacy. This will not only support the ability to shape consumer thinking, but health literacy campaigns have been shown to lift the efforts of branded commercial campaigns when the two messages are running together.

Q: What effect can point of care (POC) have on the overall media plan? What benefits can brand managers and media planners realize from adding this channel to their mix?

A: Adding POC to a plan will increase the ability to laser target reaching prospects and patients. This complements the efforts of other tactics within the plan. Secondly, POC offers a guaranteed ROI, which also enriches the promotional effectiveness of the overall marketing plan.

Q: Why is healthcare personal to you?

A: It is rewarding to be able to feel a sense of achievement from launching that new snack food item on shelf, introducing a new car model or driving purchases of yet another shade of red lipstick. However, healthcare marketing offers a benefit of knowing that you are helping people understand health conditions and offering treatment to increase their quality of life.

Q: What’s your favorite thing about being a New Yorker?

A:  New York City offers real mobility since it is one of few places in America where you have the option to walk to get to your destination rather than being tied to your car.

Linda Ruschau


July 26, 2019 0

In early June, PhRMA released its first-ever television ad as part of its Let's Talk About Cost campaign, which has previously released print, digital, and radio ads. The ad aims to “reaffirm our commitment and generate more conversation about solutions to the challenges patients face affording their medicines.”

With heightened discussion in recent times surrounding drug prices – including the US District Court's ruling on price disclosure in DTC ads and pricing trends data from Rx Savings Solutions – PhRMA's Let Talk About Cost campaign helps create transparency and encourages open “dialogue on how we can make medicines more affordable for patients,” stated their news release. According to the trade association, the campaign helps “put a spotlight on the role insurers and middlemen like pharmacy benefit managers play in determining what a patient pays out of pocket for their medicine.

“Research shows that on average, 40% of the list price of medicines is given as rebates or discounts to insurance companies, the government, pharmacy benefit managers and other entities in the supply chain. These rebates and discounts exceeded $166 billion in 2018 alone and are growing every year.”

The article's author, Priscilla VanderVeer, Vice President, Public Affairs with PhRMA, stressed the importance of focusing on “changes, like reforming the rebate system in Medicare Part D, that can lower patients’ out-of-pocket costs, improve access to cutting-edge treatments and cures, and drive competition to help bring down costs.”

admin